Back
ESC2025 Premium Access

Standard modifiable cardiovascular risk factors and prognostic outcomes in non-valvular atrial fibrillation on oral anticoagulants

Session: Anticoagulation in atrial fibrillation: striking the balance
Topic: Epidemiology, Prognosis, Outcome
Speaker: Mr H. Liu (Tianjin, CN)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Hangkuan Liu

Tianjin Medical University General Hospital, Tianjin (China)
1 follower

3 more presentations in this session

Changes in anticoagulation treatment and associated resolution or persistence of left atrial thrombus. Insights from LATTEE registry

Speaker: Associate Professor M. Gawalko (Warsaw, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Competing risks of ischemic stroke, intracranial bleeding, and mortality in patients with atrial fibrillation and prior intracranial hemorrhage without an anticoagulation regimen

Speaker: Doctor P. Tiili (Helsinki, FI)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy of anticoagulation in atrial fibrillation: evidence from 36 years of randomized controlled trials - a meta-analysis

Speaker: Mr P. Sumariva (Rio Do Sul, BR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Anticoagulation in atrial fibrillation: striking the balance

Speakers: Mr H. Liu, Associate Professor M. Gawalko, Doctor P. Tiili, Mr P. Sumariva
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources